Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
J Dermatol. 2019 May;46(5):444-448. doi: 10.1111/1346-8138.14858. Epub 2019 Mar 21.
Cyclin-dependent kinase 4 and 6 (CDK4/6) plays an important role in cell cycle progression, and the CDK4/6-cyclin D1 complex controls the cell cycle transition from G phase to S phase. CDK4 is enhanced in several types of cancers and CDK4/6 inhibitors attenuate the proliferation of several types of cancer in vitro/in vivo. The purpose of our study was to investigate the expression pattern of CDK4 and evaluate its clinical importance in extramammary Paget's disease (EMPD). Almost all EMPD tissues were positive for CDK4, and metastatic lesions had a similar immunostaining intensity to primary lesions. In addition, CDK4 protein levels were positively correlated with those of cyclin D1 protein. Taken together, CDK4 may assume a crucial role in EMPD progression.
细胞周期蛋白依赖性激酶 4 和 6(CDK4/6)在细胞周期进展中发挥重要作用,CDK4/6-细胞周期蛋白 D1 复合物控制细胞周期从 G1 期向 S 期的转变。几种类型的癌症中 CDK4 增强,CDK4/6 抑制剂在体外/体内抑制多种类型癌症的增殖。我们的研究目的是研究 CDK4 的表达模式,并评估其在乳腺外派杰病(EMPD)中的临床意义。几乎所有 EMPD 组织均为 CDK4 阳性,转移病变的免疫染色强度与原发性病变相似。此外,CDK4 蛋白水平与 cyclin D1 蛋白水平呈正相关。综上所述,CDK4 可能在 EMPD 进展中起关键作用。